SeaSpine Holdings (SPNE) Misses Q2 EPS by $1.40

SeaSpine Holdings (NASDAQ: SPNE) reported Q2 EPS of ($1.60), $1.40 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $33.5 million versus the consensus estimate of $34.11 million.

SeaSpine Holdings sees FY2015 revenue of $133-139 million.

"Following our successful spin-off from Integra LifeSciences last month, we are excited to move forward with our plans to reinvigorate SeaSpine as an independent public company," said Keith Valentine, President and Chief Executive Officer. "We are now well positioned financially to make targeted investments that leverage our existing platform of orthobiologics and spinal implants to drive future growth. We are bringing together a highly qualified team of professionals that is committed to new and next-generation product innovation and generation of clinical data, as well as expanding our distribution opportunity. I am excited by our robust pipeline of a dozen new products that we anticipate delivering over the next 24 months and the opportunity to significantly expand relationships with distributors worldwide."

For earnings history and earnings-related data on SeaSpine Holdings (SPNE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c